Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

Presentation TCT 2017

CAREMI: A Randomized Double-Blind Trial Evaluating Allogeneic Cardiac Stem Cells In Acute Myocardial Infarction

Presenter: Daniel Burkhoff, JoAnn Lindenfeld, Francisco Fdez-Aviles

October 31, 2017

Presentation TCT 2017

New Products: Ixmyelocel and Allogeneic Mesenchymal Stem Cells

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Timothy D. Henry

October 31, 2017

Presentation TCT 2015

Debate: Are We Really Ready for Phase III Trials? Yes, Mesenchymal Cells Are Ready to Be Tested for Prevention and Treatment of Chronic Ischemic and Nonischemic Heart Failure!

Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Emerson C. Perin

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiac Progenitor Cells Are the Only One!

Presenter: Nabil Dib, Philippe Menasché, Timothy D. Henry

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Combination of Cells for Additive Effects: This Is the Key!

Presenter: Nabil Dib, Philippe Menasché, Jay H Traverse

October 15, 2015

Presentation TCT 2015

Stem Cells in Biology of the Adult Myocardium: Are Biomaterials the Missing Link?

Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Jay H Traverse

October 15, 2015

Presentation TCT 2014

ALLogeneic Heart STem Cells To Achieve Myocardial Regeneration (ALLSTAR): The Six-Month Phase I Safety Results

Presenter: Daniel Burkhoff, William W. O'Neill, Jose Luis Assad-Morell, Raj Makkar

September 16, 2014

Presentation TCT 2014

Impact of Intracoronary Injection of CD133+ Bone Marrow Stem Cells on Coronary Atherosclerotic Progression in Patients with STEMI: A COMPARE-AMI IVUS Substudy

Presenter: Fuyu Qiu

September 16, 2014

Presentation TCT 2014

Different Dose of Stem Cells Transplantation in patients with Acute Myocardial Infarction: a Meta-analysis

Presenter: Rongchong Huang

September 16, 2014

Presentation TCT 2014

TCT 150: First-in-Man Experience with Transendocardial Injections of Bone Marrow-Derived Mesenchymal Stem Cells in Idiopathic Dilated Cardiomyopathy: The MYOCYTE Trial

Presenter: Marc S. Penn, Andreas M. Zeiher, Warren Sherman, Ricardo Sanz-Ruiz, MD

September 15, 2014

Presentation TCT 2014

Cellular Nanotechnology in STEMI

Presenter: Marc S. Penn, Andreas M. Zeiher, Warren Sherman, Jonathan Leor

September 15, 2014

Presentation TCT 2013

Intracoronary Infusion of Bone Marrow Mesenchymal Stem Cells in Acute Myocardial Infarction- A Critical Challenge for Dosage-Related Efficacy and Safety

Presenter: Lian R. Gao

October 29, 2013

Presentation TCT 2013

Allogeneic Cardiac-Derived Cells for STEMI

Presenter: Raj Makkar

October 29, 2013

News Conference News TCT 2012

Future Looks Bright for Stem Cell-Based Myocardial Therapy

October 26, 2012

Presentation TCT 2012

Autologous Cardiac Stem Cells in VAD Patients

Presenter: Robert Michler

October 23, 2012

Presentation TCT 2012

Autologous vs. Allogeneic Cardiac Stem Cells: The Allstar Trial

Presenter: Raj Makkar

October 22, 2012

Presentation TCT 2012

AMICI: Use of Mesenchymal Precursor Cells in the Treatment of STEMI Patients (FIM/IIB Study)

Presenter: Henricus Duckers

October 22, 2012

News Conference News

Preclinical Results Promising for Combo Stent

November 08, 2011

News Conference News

Stem Cells Derived from Body Fat Improved Certain Cardiac Outcomes

November 06, 2011

News Conference News

New Stem Cell Therapies Promising in Severe Heart Disease

November 06, 2011

Advertisement

CAREMI: A Randomized Double-Blind Trial Evaluating Allogeneic Cardiac Stem Cells In Acute Myocardial Infarction

New Products: Ixmyelocel and Allogeneic Mesenchymal Stem Cells

Debate: Are We Really Ready for Phase III Trials? Yes, Mesenchymal Cells Are Ready to Be Tested for Prevention and Treatment of Chronic Ischemic and Nonischemic Heart Failure!

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiac Progenitor Cells Are the Only One!

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Combination of Cells for Additive Effects: This Is the Key!

Stem Cells in Biology of the Adult Myocardium: Are Biomaterials the Missing Link?

ALLogeneic Heart STem Cells To Achieve Myocardial Regeneration (ALLSTAR): The Six-Month Phase I Safety Results

Impact of Intracoronary Injection of CD133+ Bone Marrow Stem Cells on Coronary Atherosclerotic Progression in Patients with STEMI: A COMPARE-AMI IVUS Substudy

Different Dose of Stem Cells Transplantation in patients with Acute Myocardial Infarction: a Meta-analysis

TCT 150: First-in-Man Experience with Transendocardial Injections of Bone Marrow-Derived Mesenchymal Stem Cells in Idiopathic Dilated Cardiomyopathy: The MYOCYTE Trial

Cellular Nanotechnology in STEMI

Intracoronary Infusion of Bone Marrow Mesenchymal Stem Cells in Acute Myocardial Infarction- A Critical Challenge for Dosage-Related Efficacy and Safety

Allogeneic Cardiac-Derived Cells for STEMI

Future Looks Bright for Stem Cell-Based Myocardial Therapy

Autologous Cardiac Stem Cells in VAD Patients

Autologous vs. Allogeneic Cardiac Stem Cells: The Allstar Trial

AMICI: Use of Mesenchymal Precursor Cells in the Treatment of STEMI Patients (FIM/IIB Study)

Preclinical Results Promising for Combo Stent

Stem Cells Derived from Body Fat Improved Certain Cardiac Outcomes

New Stem Cell Therapies Promising in Severe Heart Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content